drug
Radicava
Marketedupdated 3mo agoby $SGIOF SHIONOGI & CO LTD
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Radicava
- phase2Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL
- phase1Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects
- phase4Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke
- phase2Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
- —Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
- phase3Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that